Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trichomylin in Advanced Cancer Pain
NCT06533657Phase 2Completed
- Sponsor
- ZYUS Life Sciences Corporation
- Start
- Jun 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Trichomylin in cancer pain, sponsored by ZYUS Life Sciences Corporation. Started Jun 2025; status: completed.
02
Drugs
Trichomylin
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT06533657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06533657.